1. C-reactive protein and coronary events following percutaneous coronary angioplasty 
Robbert J de Winter, MD, PhD, Karel T Koch, MD, PhD, Jan P van Straalen, Gerlind Heyde, MD, Matthijs Bax, MD, Carl E Schotborgh, MD, Karla J Mulder, Gerard T Sanders, PhD, Johan Fischer, PhD, Jan G.P Tijssen, PhD, Jan J Piek, MD, PhD 
The American Journal of Medicine 
Volume 115, Issue 2, Pages (August 2003)
DOI: /S (03)

2. Figure 1
Cumulative probability of death or nonfatal myocardial infarction (MI) following percutaneous coronary angioplasty, by C-reactive protein level (P <0.0001).
The American Journal of Medicine  , 85-90DOI: ( /S (03) )

3. Figure 2
Cumulative probability of repeat revascularization (percutaneous transluminal angioplasty [PTCA] or coronary artery bypass graft [CABG] surgery) following percutaneous coronary angioplasty, by C-reactive protein level (P =0.24).
The American Journal of Medicine  , 85-90DOI: ( /S (03) )